Caris Life Sciences Inc (CAI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | N/A | -150,045 | -174,370 | -281,890 | -244,943 |
| Depreciation Amortization | N/A | 30,487 | 23,154 | 55,967 | 44,995 |
| Accounts receivable | N/A | 61,232 | 37,040 | N/A | -15,009 |
| Accounts payable and accrued liabilities | N/A | -1,196 | -1,925 | N/A | 5,054 |
| Other Working Capital | N/A | 25,969 | 11,882 | -29,067 | -22,099 |
| Other Operating Activity | 0 | 71,928 | 80,169 | 9,791 | 25,724 |
| Operating Cash Flow | $N/A | $38,375 | $-24,050 | $-245,199 | $-206,278 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | N/A | N/A | 61,376 |
| PPE Investments | N/A | -11,170 | -4,075 | -8,444 | -6,154 |
| Other Investing Activity | 0 | 0 | 0 | 61,376 | 0 |
| Investing Cash Flow | $N/A | $-11,170 | $-4,075 | $52,932 | $55,222 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 27,865 | 27,865 | N/A | 199,978 |
| Debt Repayment | N/A | -67 | -44 | N/A | -136 |
| Common Stock Issued | N/A | 542,504 | 541,353 | N/A | 1,258 |
| Common Stock Repurchased | N/A | -22 | -22 | N/A | N/A |
| Other Financing Activity | 0 | 91,310 | 113,535 | 200,292 | -1,034 |
| Financing Cash Flow | $N/A | $661,590 | $682,687 | $200,292 | $200,066 |
| Exchange Rate Effect | N/A | 159 | 97 | -4 | -3 |
| Beginning Cash Position | N/A | 68,028 | 68,028 | 60,007 | 60,007 |
| End Cash Position | N/A | 756,982 | 722,687 | 68,028 | 109,014 |
| Net Cash Flow | $N/A | $688,954 | $654,659 | $8,021 | $49,007 |
| Free Cash Flow | |||||
| Operating Cash Flow | N/A | 38,375 | -24,050 | -245,199 | -206,278 |
| Capital Expenditure | N/A | -11,170 | -4,075 | N/A | -6,154 |
| Free Cash Flow | 0 | 27,205 | -28,125 | -245,199 | -212,432 |